Anhydrous Dicalcium Phosphate: Its Importance in These Three High-Value Sectors

Anhydrous dicalcium phosphate (DCPA) is an important inorganic functional material widely used in fields such as pharmaceuticals, bone repair, and food additives. In the pharmaceutical industry, DCPA primarily serves as a filler, diluent, and auxiliary disintegrant for tablets and capsules. In the field of bone repair, it can exist either as a single phase or in combination with other calcium phosphate phases; as a novel material for repairing bone defects, it shows great promise for biomedical applications. In the animal feed sector, DCPA acts as a highly efficient dual-source calcium and phosphorus supplement, promoting skeletal development and enhancing the production performance of livestock and poultry. In the food industry, it is commonly used as a nutritional fortifier and anti-caking agent. Given this diverse range of applications, DCPA is attracting increasing attention from researchers.

Anhydrous dicalcium phosphate (DCPA) appears as an odorless, tasteless white powder and exists in a triclinic crystalline form (also known as monetite). Its unit cell is held together by a combination of three types of hydrogen bonds and Ca-O bonds. It is virtually insoluble in water or ethanol but readily soluble in dilute hydrochloric or nitric acid. Stable at room temperature, it is non-hygroscopic and does not undergo phase transitions or hydration to form the dihydrate; however, it converts to calcium pyrophosphate at high temperatures. The primary deformation mechanism of DCPA is brittle fracture, which reduces strain sensitivity and facilitates the transition from laboratory-scale trial production to industrial-scale application.

The global market for anhydrous dicalcium phosphate continues to expand steadily, with a projected compound annual growth rate of 5.5% over the next five years. Growth is driven primarily by three key downstream sectors: animal feed, pharmaceuticals, and food.

The animal feed sector accounts for the largest share; as a highly efficient calcium and phosphorus supplement, the product’s core function of promoting skeletal development and enhancing the productivity of livestock and poultry drives sustained demand alongside the global rise in meat consumption, while the trend toward quality upgrading further boosts usage volumes.

Although the pharmaceutical sector represents a relatively smaller market share, it offers high product value-added and significant growth potential. High-purity, pharmaceutical-grade anhydrous dicalcium phosphate is widely used in oral solid dosage forms as a filler, disintegrant, and dissolution enhancer, playing a particularly crucial role in improving the bioavailability of poorly soluble drugs. Driven by the expansion of the global generic drug market, advancements in novel formulation technologies, and increasing demands for patient medication adherence, the demand for pharmaceutical-grade products continues to rise, creating structural opportunities within the market.

From a regional perspective, the Asia-Pacific region—led by China—is emerging as the fastest-growing market for anhydrous dicalcium phosphate globally, benefiting from a massive livestock industry, a rapidly developing pharmaceutical sector, and a continuously upgrading consumer market.

Thanks to its high purity, excellent biocompatibility, and stable physicochemical properties, anhydrous dicalcium phosphate demonstrates irreplaceable value in applications such as pharmaceutical excipients, bone repair materials, and feed additives. Looking ahead, the market potential for anhydrous dicalcium phosphate is poised for further expansion, driven by the convergence of several factors: rising demand for bone health solutions amidst an aging population, the booming development of generics and biologics, and the large-scale expansion of global livestock and poultry farming.